List view / Grid view
In this article, we investigate three of the latest developments…
In this article, we investigate three of the latest developments in COVID-19 therapeutics that are delivered intranasally.
The trial will assess the safety and immunogenicity of a…
The trial will assess the safety and immunogenicity of a single intranasal dose of COVI-VAC in 48 healthy volunteers in the UK.
As the COVID-19 pandemic and the search for an effective…
As the COVID-19 pandemic and the search for an effective preventative vaccine continues, the Serum Institute of India has entered into manufacturing agreements with both Novavax and Codagenix to help supply their experimental COVID-19 vaccine candidates.
